Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Factor: 50% Off Your First Box
Unboxing this meal kit company’s enticing offer.
Perimenopause is the new buzzword in the business of women’s health
Sarah Todd, Stat News
Will Walmart Ever Take Responsibility for Deception on Its Site?
TINA.org finds more of the same – and then some – from retail giant.
Amazon to Pay $2.5 Billion to Settle Trickery Charges Related to Prime
FTC lawsuit alleged company duped consumers into signing up and then made it hard to cancel.
Memory Defender
Your best defense against deceptive AI? A little research.